Steris (STE) Net Income Growth (1y) (2019 - 2025)
Steris (STE) Net Income Growth (1y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.51 Bn | 174.22 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.20 Bn | 125.32 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.69 Bn | 98.47 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 68.05 Bn | 66.59 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 47.52 Bn | 43.85 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 28.46 Bn | 26.17 Bn | 1.98 Bn | -30.10% |
| 7 | Dexcom | 28.25 Bn | 27.13 Bn | 750.30 Mn | 89.28% |
| 8 | Smith & Nephew | 26.73 Bn | 26.15 Bn | - | - |
| 9 | Koninklijke Philips | 25.31 Bn | 22.19 Bn | 2.07 Bn | 125.69% |
| 10 | Steris | 21.43 Bn | 20.99 Bn | 697.10 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 99.48% |
| Dec 31, 2024 | 98.69% |
| Sep 30, 2024 | 95.51% |
| Jun 30, 2024 | 182.46% |
| Mar 31, 2024 | -3,338.22% |
| Dec 31, 2023 | 0.29% |
| Sep 30, 2023 | 98.99% |
| Jun 30, 2023 | 18.48% |
| Mar 31, 2023 | -94.91% |
| Dec 31, 2022 | -105.37% |
| Sep 30, 2022 | -730.72% |
| Jun 30, 2022 | 61.97% |
| Mar 31, 2022 | 7.95% |
| Dec 31, 2021 | 24.88% |
| Sep 30, 2021 | -34.32% |
| Jun 30, 2021 | -124.46% |
| Mar 31, 2021 | -41.52% |
| Dec 31, 2020 | 9.48% |
| Sep 30, 2020 | 11.42% |
| Jun 30, 2020 | -9.70% |